Docosahexaenoic acid for the reduction of bronchopulomonary dysplasia in preterm infants born at less than 29 weeks gestational age: a randomised controlled trial [ 2012 - 2015 ]

Also known as: DHA for the reduction of bronchopulmonary dysplasia in premature babies.

Research Grant

[Cite as]

Researchers: Dr Carmel Collins (Principal investigator) ,  A/Pr Victor Rajadurai Dr Andrew Mcphee Dr Marta Thio Mr Thomas Sullivan
View all 7 related researchers

Brief description A major challenge in the care of very preterm babies, is dealing with the fact that the baby has very immature lungs. They are prone to an inflammatory condition known as BPD (broncho-pulmonary dysplasia) that prevents an infant from breathing, much like asthma in older children. This can result in poor health outcomes for life. Our study will test the effect of the omega 3 fat known as DHA in reducing this inflammation in the lung and result in better outcomes for the baby.

Funding Amount $AUD 1,929,854.16

Funding Scheme Project Grants

Notes Standard Project Grant

Click to explore relationships graph
Viewed: [[ro.stat.viewed]]